Septerna, Inc.
SEPN · XNASCIK 1984086fmd_00T3HN8WK3HJ1E8KZ00J7RXV2XManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 15 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 0 | 1 | 46 |
| Research and development | 36 | 65 | 98 |
| Total operating expenses | (2) | 82 | 114 |
| Operating income | 2 | (81) | (68) |
| Interest and investment income | 3 | 9 | 20 |
| Other non-operating income (expense) | 3 | 9 | 19 |
| Income before taxes | (49) | (72) | (49) |
| Income tax expense | 1 | (0) | 0 |
| Net income from continuing operations | (50) | (72) | (49) |
| Net income | 4 | (72) | (49) |
| Net income to common shareholders | 1 | (72) | – |